Suscribirse

Rationale and design of the French Observatory of Acute Heart Failure (OFICA2) - 25/09/24

Doi : 10.1016/j.acvd.2024.05.120 
Claire Bouleti a, , Benjamin Alos a, Damien Legallois b, Romain Eschalier c, r, Jerome Costa d, Victoria Tea e, Jean-Noel Trochu f, Guillaume Turlotte g, Julie Perrin-Faurie h, Teodora Dutoiu i, François Picard j, Gregory Ducrocq k, Pascal de Groote l, s, Thierry Laperche m, Clement Delmas n, Ariel Cohen o, Maxime Doublet p, Damien Logeart q
a Cardiology Department, University Hospital of Poitiers, Clinical Investigation Center (Inserm 1402), Poitiers, France 
b Cardiology Department, University Hospital of Caen, Caen, France 
c Cardiology Department, CHU Clermont-Ferrand, 63000 Clermont-Ferrand, France 
d Cardiology Department, University Hospital of Reims, Reims, France 
e Cardiology Department, European Hospital Georges Pompidou, AP–HP, Paris, France 
f Cardiology Department, University Hospital of Nantes, Nantes, France 
g Cardiology Department, La Roche-sur-Yon Hospital, La-Roche-Sur-Yon, France 
h Cardiology Department, Hospital Metropole Savoie, Chambery, France 
i Cardiology Department, Chartres Hospital, Le Coudray, France 
j Cardiology Department, University Hospital of Bordeaux, Pessac, France 
k Cardiology Department, Bichat University Hospital, AP–HP, Paris, France 
l Service de Cardiologie, CHU Lille, 59000 Lille, France 
m Cardiology Department, Centre Cardiologique du Nord, Saint-Denis, France 
n Cardiology Department, University Hospital of Toulouse, Toulouse, France 
o Cardiology Department, Saint-Antoine University Hospital, AP–HP, Paris, France 
p Clinityx Company, Paris, France 
q Inserm U942, Paris Cité University, AP–HP, Hôpital Lariboisière, 75010 Paris, France 
r Université Clermont Auvergne, CNRS, SIGMA Clermont, Institut Pascal, 63000 Clermont-Ferrand, France 
s Inserm U1167, Institut Pasteur de Lille, 59000 Lille, France 

Corresponding author. Cardiology Department, University of Poitiers, Clinical Investigation Center (Inserm 1402), 2, rue de la Milétrie, 86000 Poitiers, France.Cardiology Department, University of Poitiers, Clinical Investigation Center (Inserm 1402)2, rue de la MilétriePoitiers86000France

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Graphical abstract




El texto completo de este artículo está disponible en PDF.

Highlights

OFICA2 is a large prospective database on acute heart failure (AHF) in France.
It included 1513 patients with AHF in 80 centers during a 3-week period in 2021.
National Health Database linkage will provide information during the 2 years before AHF.
Accurate 3-year follow-up will be ensured by the same linkage.
OFICA2 will provide contemporary data on AHF management and prognostic determinants.

El texto completo de este artículo está disponible en PDF.

Abstract

Background

Acute heart failure (AHF) is a leading cause of hospitalization and mortality – especially in patients aged65 years in high-income countries – and represents a high healthcare burden. In the past decade, the epidemiology and management of heart failure (HF) has changed, with the emergence of new medical and interventional therapeutics, but up-to-date real-life data are scarce.

Aims

The main objectives are to describe baseline characteristics (with an emphasis on lifestyle, cognitive status, HF knowledge and treatment adherence), management, and in-hospital and mid-term outcomes of AHF patients in France. Secondary objectives are to investigate determinants of prognosis, modalities of treatment and follow-up, and identify gaps between guidelines and real-life management.

Methods

OFICA2 is a prospective multicentre observational survey that enrolled 1513 patients hospitalized for AHF in 80 participating centres in France during March and April 2021. The diagnosis of AHF was made according to the European Society of Cardiology guidelines definition. Inclusion criteria were age18years, health coverage and consent to participate. Detailed information was collected prospectively starting at admission. Thanks to direct linking with the French National Health Database, the anteriority up to 2years before inclusion, as well as a 3-year follow-up is specified for each patient and includes individual information on death, hospital admissions, major clinical events, drug delivery and use of reimbursed health resources.

Conclusion

This cohort provides a representative snapshot on contemporary AHF, with a particular focus on self-care determinants, and will improve knowledge about AHF presentation, management and outcomes.

El texto completo de este artículo está disponible en PDF.

Keywords : Acute heart failure, Healthcare pathway, Prognosis


Esquema


© 2024  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 117 - N° 8-9

P. 514-520 - août 2024 Regresar al número
Artículo precedente Artículo precedente
  • His bundle pacing versus left bundle branch area pacing in patients undergoing atrioventricular node ablation: A prospective and comparative study
  • Corentin Chaumont, Maxime Azincot, Arnaud Savouré, Nathanael Auquier, Raphaël Al Hamoud, Elena Popescu, Guillaume Viart, Adrian Mirolo, Hélène Eltchaninoff, Frédéric Anselme
| Artículo siguiente Artículo siguiente
  • Cardiac rehabilitation recommendations of the Group Exercise Rehabilitation Sports – Prevention (GERS-P) of the French Society of Cardiology: 2023 update
  • Muriel Bigot, Jean Michel Guy, Catherine Monpere, Alain Cohen-Solal, Bruno Pavy, Marie Christine Iliou, Gilles Bosser, Sonia Corone, Herve Douard, Titi Farrokhi, Antoine Guerder, Pascal Guillo, Jean-Pierre Houppe, Theo Pezel, Bernard Pierre, Stephane Roueff, Daniel Thomas, Benedicte Verges, Jean Christophe Blanchard, Mohamed Ghannem, Dany Marcadet

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.